Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Non Small Cell Lung Cancer|Metastatic Breast Cancer|Metastatic Non-Small Cell Lung Carcinoma
Interventions: RADIATION: Stereotactic Body Radiotherapy/SBRT|DRUG: Systemic Therapy/Standard of Care
Sponsor: Memorial Sloan Kettering Cancer Center